1161160

Eli Lilly & Company — FEI 1819470

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
January 13, 2022
Fiscal Year
2022
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Indianapolis, IN (United States)

Additional Details

Sponsor, Contract Research Organization